Bingham Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$525K Sell
1,492
-19
-1% -$6.77K 0.42% 73
2025
Q4
$495K Buy
+1,511
New +$479K 0.43% 75
2025
Q2
$393K Sell
1,407
-1
-0.1% -$283 0.37% 88
2025
Q1
$439K Buy
1,408
+305
+28% +$90.1K 0.45% 74
2024
Q4
$287K Buy
+1,103
New +$327K 0.31% 104

Other funds holding AMGN

Bingham Private Wealth's AMGN Position: Q1 2026 in Review

Bingham Private Wealth reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $6.77K and leaving 1,492 shares worth $525K. The position accounts for 0.42% of the portfolio, ranked #73.

Bingham Private Wealth first reported a position in AMGN in Q4 2024 and has held it in 5 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bingham Private Wealth held 1,492 shares of Amgen worth $525K as of Q1 2026.
  • Bingham Private Wealth sold 19 Amgen shares in Q1 2026, an estimated $6.77K.
  • Amgen made up 0.42% of Bingham Private Wealth's portfolio in Q1 2026, its #73 holding.
  • Bingham Private Wealth first reported a position in Amgen in Q4 2024 and has held it in 5 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bingham Private Wealth's 13F filing for Q1 2026, filed 7 May 2026.